RT Journal Article
SR Electronic
T1 Predictive validity of the simplified Radiographic Assessment of Lung Edema score for the mortality in critically ill COVID-19 patients with the B.1.617.2 (Delta) variant in Vietnam: a single-centre, cross-sectional study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.20.24304599
DO 10.1101/2024.03.20.24304599
A1 Do, Son Ngoc
A1 Dang, Tuan Quoc
A1 Luong, Chinh Quoc
A1 Nguyen, My Ha
A1 Pham, Dung Thi
A1 Nguyen, Viet Khoi
A1 Do, Tan Dang
A1 Nguyen, Thai Quoc
A1 Nong, Vuong Minh
A1 Vo, Khoi Hong
A1 Nguyen, Tan Cong
A1 Khuat, Nhung Hong
A1 Pham, Quynh Thi
A1 Hoang, Dat Tien
A1 Nguyen, Anh Diep
A1 Nguyen, Phuong Minh
A1 Cao, Duong Dai
A1 Pham, Dung Thuy
A1 Dang, Dung Tuan
A1 Nguyen, Dat Tuan
A1 Nguyen, Vinh Duc
A1 Le, Thuan Quang
A1 Ngo, Hung Duc
A1 Nguyen, Dung Van
A1 Pham, Thach The
A1 Nguyen, Dung Tien
A1 Nguyen, Nguyen Trung
A1 Huynh, Nhung Thi
A1 Phan, Nga Thu
A1 Nguyen, Cuong Duy
A1 Vu, Thom Thi
A1 Do, Cuong Duy
A1 Nguyen, Chi Van
A1 Vu, Giap Van
A1 Dao, Co Xuan
YR 2024
UL http://medrxiv.org/content/early/2024/03/22/2024.03.20.24304599.abstract
AB Background Evaluating the prognosis of COVID-19 patients who may be at risk of mortality using the simple chest X-ray (CXR) severity scoring systems provides valuable insights for treatment decisions. This study aimed to assess how well the simplified Radiographic Assessment of Lung Edema (RALE) score could predict the death of critically ill COVID-19 patients in Vietnam.Methods From July 30 to October 15, 2021, we conducted a cross-sectional study on critically ill COVID-19 adult patients at an intensive care centre in Vietnam. We calculated the areas under the receiver operator characteristic (ROC) curve (AUROC) to determine how well the simplified RALE score could predict hospital mortality. In a frontal CXR, the simplified RALE score assigns a score to each lung, ranging from 0 to 4. The overall severity score is the sum of points from both lungs, with a maximum possible score of 8. We also utilized ROC curve analysis to find the best cut-off value for this score. Finally, we utilized logistic regression to identify the association of simplified RALE score with hospital mortality.Results Of 105 patients, 40.0% were men, the median age was 61.0 years (Q1-Q3: 52.0-71.0), and 79.0% of patients died in the hospital. Most patients exhibited bilateral lung opacities on their admission CXRs (99.0%; 100/102), with the highest occurrence of opacity distribution spanning three (18.3%; 19/104) to four quadrants of the lungs (74.0%; 77/104) and a high median simplified RALE score of 8.0 (Q1-Q3: 6.0-8.0). The simplified RALE score (AUROC: 0.747 [95% CI: 0.617-0.877]; cut-off value ≥5.5; sensitivity: 93.9%; specificity: 45.5%; PAUROC <0.001) demonstrated a good discriminatory ability in predicting hospital mortality. After adjusting for confounding factors such as age, gender, Charlson Comorbidity Index, serum interleukin-6 level upon admission, and admission severity scoring systems, the simplified RALE score of ≥5.5 (adjusted OR: 18.437; 95% CI: 3.215-105.741; p =0.001) was independently associated with an increased risk of hospital mortality.Conclusions This study focused on a highly selected cohort of critically ill COVID-19 patients with a high simplified RALE score and a high mortality rate. Beyond its good discriminatory ability in predicting hospital mortality, the simplified RALE score also emerged as an independent predictor of hospital mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Scientific and Ethics Committees of Bach Mai Hospital (Approval number: 3412/Đ-BM) and conducted according to the principles of the Declaration of Helsinki. The Bach Mai Hospital Scientific and Ethics Committees waived the written informed consent for this non-interventional study. Public notification of this study was made by published posting, according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration - the STROBE Statement - Checklist of items that should be included in reports of cross-sectional studies. The authors who performed the data analysis kept the data set in password-protected systems and only presented anonymized data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files.